CYRX
Cryoport, Inc.
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Operating Income
$-36806000
↑ 71.9%
Revenue
$176.2M
↓ 22.9%
Gross Profit
$83.1M
↓ 16.6%
EPS (Diluted)
$1.40
↑ 156.2%
Total Liabilities
$262.4M
↓ 13.0%
Net Income
$78.3M
↑ 168.2%
Cash & Equivalents
$250.5M
↑ 453.1%
Shareholders' Equity
$502.6M
↑ 25.1%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/14/2026 View on SEC
SCHEDULE 13G/A 8/13/2026 View on SEC
4 8/11/2026 View on SEC
144 8/11/2026 View on SEC
10-Q 8/6/2026 View on SEC
8-K 8/6/2026 View on SEC
SCHEDULE 13G/A 7/29/2026 View on SEC
S-8 6/22/2026 View on SEC
15-12G 6/22/2026 View on SEC
4 6/12/2026 View on SEC

Company Information

Field Value
Ticker CYRX
Company Name Cryoport, Inc.
CIK 1124524
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation NV
Phone (949) 232-1900